| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchoscopy | 58 | 2024 | 162 | 16.350 |
Why?
|
| Airway Obstruction | 25 | 2024 | 109 | 9.000 |
Why?
|
| Lung Neoplasms | 29 | 2024 | 2370 | 4.150 |
Why?
|
| Tracheobronchomalacia | 8 | 2020 | 11 | 3.370 |
Why?
|
| Tracheal Stenosis | 10 | 2025 | 25 | 3.270 |
Why?
|
| Pulmonary Medicine | 10 | 2024 | 46 | 3.240 |
Why?
|
| Endosonography | 11 | 2022 | 99 | 3.120 |
Why?
|
| Stents | 14 | 2024 | 412 | 3.020 |
Why?
|
| Laryngostenosis | 5 | 2025 | 18 | 2.360 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 14 | 2022 | 1131 | 2.350 |
Why?
|
| Pleural Effusion, Malignant | 3 | 2024 | 16 | 2.110 |
Why?
|
| Bronchial Diseases | 6 | 2016 | 14 | 2.010 |
Why?
|
| Image-Guided Biopsy | 6 | 2021 | 78 | 1.810 |
Why?
|
| Pneumonectomy | 5 | 2020 | 211 | 1.560 |
Why?
|
| Laser Therapy | 7 | 2019 | 148 | 1.520 |
Why?
|
| Lung Diseases | 5 | 2019 | 275 | 1.460 |
Why?
|
| Patient Care Team | 3 | 2024 | 284 | 1.440 |
Why?
|
| Tracheostomy | 6 | 2021 | 46 | 1.410 |
Why?
|
| Robotic Surgical Procedures | 3 | 2022 | 319 | 1.400 |
Why?
|
| Respiratory Insufficiency | 4 | 2020 | 162 | 1.310 |
Why?
|
| Problem-Based Learning | 3 | 2018 | 35 | 1.290 |
Why?
|
| Humans | 96 | 2025 | 89970 | 1.260 |
Why?
|
| Positive-Pressure Respiration | 4 | 2014 | 40 | 1.250 |
Why?
|
| Pneumothorax | 6 | 2021 | 53 | 1.240 |
Why?
|
| Ablation Techniques | 3 | 2019 | 38 | 1.160 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 4 | 2021 | 25 | 1.040 |
Why?
|
| Pleural Effusion | 2 | 2024 | 47 | 1.020 |
Why?
|
| Respiratory System | 3 | 2021 | 117 | 0.980 |
Why?
|
| Tracheal Diseases | 4 | 2009 | 15 | 0.940 |
Why?
|
| Photochemotherapy | 6 | 2023 | 100 | 0.920 |
Why?
|
| Sarcoidosis | 2 | 2023 | 72 | 0.920 |
Why?
|
| Clinical Competence | 6 | 2017 | 796 | 0.900 |
Why?
|
| Tomography, Optical Coherence | 4 | 2013 | 137 | 0.900 |
Why?
|
| Pulmonologists | 1 | 2023 | 7 | 0.890 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 32 | 0.880 |
Why?
|
| Palliative Care | 3 | 2016 | 264 | 0.860 |
Why?
|
| Asthma | 5 | 2020 | 984 | 0.850 |
Why?
|
| Trachea | 4 | 2013 | 292 | 0.780 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2020 | 264 | 0.760 |
Why?
|
| Pleurodesis | 2 | 2020 | 8 | 0.760 |
Why?
|
| Stakeholder Participation | 1 | 2021 | 22 | 0.750 |
Why?
|
| Respiration, Artificial | 4 | 2021 | 358 | 0.750 |
Why?
|
| Biopsy | 6 | 2020 | 1184 | 0.730 |
Why?
|
| Lymphadenopathy | 1 | 2021 | 20 | 0.730 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2021 | 2677 | 0.720 |
Why?
|
| Pulmonary Emphysema | 3 | 2019 | 37 | 0.710 |
Why?
|
| Muscular Diseases | 1 | 2020 | 64 | 0.710 |
Why?
|
| Bronchi | 5 | 2017 | 230 | 0.700 |
Why?
|
| Betacoronavirus | 2 | 2020 | 262 | 0.700 |
Why?
|
| Anesthesia, Intravenous | 1 | 2019 | 35 | 0.680 |
Why?
|
| Neuromuscular Blockade | 1 | 2019 | 26 | 0.670 |
Why?
|
| Neoplasm Staging | 8 | 2022 | 2000 | 0.670 |
Why?
|
| Lymphoma | 1 | 2021 | 266 | 0.650 |
Why?
|
| Drainage | 1 | 2020 | 165 | 0.640 |
Why?
|
| Emphysema | 2 | 2019 | 23 | 0.640 |
Why?
|
| B7-H1 Antigen | 2 | 2017 | 278 | 0.620 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 319 | 0.610 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 305 | 0.610 |
Why?
|
| Dyspnea | 3 | 2016 | 76 | 0.610 |
Why?
|
| Cartilage Diseases | 2 | 2007 | 18 | 0.550 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 106 | 0.550 |
Why?
|
| Tracheal Neoplasms | 2 | 2013 | 8 | 0.540 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2020 | 1352 | 0.520 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 338 | 0.520 |
Why?
|
| Dilatation | 2 | 2013 | 48 | 0.510 |
Why?
|
| Health Personnel | 1 | 2017 | 214 | 0.500 |
Why?
|
| Military Personnel | 1 | 2017 | 92 | 0.500 |
Why?
|
| Lung | 7 | 2023 | 1292 | 0.490 |
Why?
|
| Thoracoscopy | 1 | 2015 | 23 | 0.490 |
Why?
|
| Prostheses and Implants | 2 | 2019 | 125 | 0.490 |
Why?
|
| Mediastinal Neoplasms | 1 | 2015 | 46 | 0.490 |
Why?
|
| Pleura | 1 | 2015 | 31 | 0.490 |
Why?
|
| Device Removal | 1 | 2016 | 168 | 0.480 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 129 | 0.470 |
Why?
|
| Respiratory Tract Diseases | 1 | 2014 | 45 | 0.450 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 490 | 0.450 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2013 | 17 | 0.450 |
Why?
|
| Physicians | 1 | 2021 | 692 | 0.430 |
Why?
|
| Aged | 18 | 2022 | 19254 | 0.420 |
Why?
|
| Retrospective Studies | 10 | 2022 | 9210 | 0.420 |
Why?
|
| Postoperative Complications | 2 | 2016 | 2314 | 0.420 |
Why?
|
| Silicones | 2 | 2009 | 20 | 0.410 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2021 | 107 | 0.410 |
Why?
|
| Constriction, Pathologic | 4 | 2021 | 222 | 0.410 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 1098 | 0.410 |
Why?
|
| Male | 25 | 2021 | 42682 | 0.390 |
Why?
|
| Diagnostic Errors | 1 | 2013 | 160 | 0.390 |
Why?
|
| Catheters, Indwelling | 2 | 2024 | 114 | 0.380 |
Why?
|
| Pandemics | 4 | 2022 | 778 | 0.380 |
Why?
|
| Quality of Life | 6 | 2024 | 1682 | 0.360 |
Why?
|
| Bronchoscopes | 1 | 2010 | 4 | 0.360 |
Why?
|
| Respiratory Mechanics | 2 | 2009 | 102 | 0.350 |
Why?
|
| Societies, Medical | 3 | 2024 | 584 | 0.340 |
Why?
|
| Bronchial Fistula | 1 | 2009 | 9 | 0.340 |
Why?
|
| Ultrasonography | 3 | 2019 | 720 | 0.340 |
Why?
|
| Bronchial Neoplasms | 1 | 2009 | 9 | 0.330 |
Why?
|
| Middle Aged | 17 | 2021 | 26148 | 0.320 |
Why?
|
| Respiratory Function Tests | 3 | 2021 | 140 | 0.320 |
Why?
|
| Critical Care | 2 | 2011 | 384 | 0.310 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2009 | 56 | 0.310 |
Why?
|
| Ultrasonography, Interventional | 2 | 2020 | 124 | 0.310 |
Why?
|
| Female | 20 | 2021 | 46595 | 0.310 |
Why?
|
| Lymphatic Metastasis | 3 | 2021 | 495 | 0.310 |
Why?
|
| Argon Plasma Coagulation | 2 | 2019 | 6 | 0.310 |
Why?
|
| Electrocoagulation | 2 | 2019 | 23 | 0.300 |
Why?
|
| Specimen Handling | 2 | 2020 | 103 | 0.280 |
Why?
|
| Lymph Nodes | 3 | 2021 | 550 | 0.280 |
Why?
|
| Forced Expiratory Volume | 3 | 2014 | 126 | 0.270 |
Why?
|
| Papilloma | 2 | 2020 | 22 | 0.260 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2019 | 841 | 0.260 |
Why?
|
| Intubation, Intratracheal | 2 | 2020 | 147 | 0.260 |
Why?
|
| Prospective Studies | 7 | 2023 | 4331 | 0.240 |
Why?
|
| Outpatients | 1 | 2024 | 101 | 0.220 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2023 | 17 | 0.220 |
Why?
|
| Prevalence | 2 | 2023 | 1250 | 0.220 |
Why?
|
| Evidence-Based Medicine | 3 | 2021 | 435 | 0.210 |
Why?
|
| Chest Tubes | 2 | 2020 | 24 | 0.210 |
Why?
|
| Patient Selection | 3 | 2021 | 682 | 0.200 |
Why?
|
| Pulmonary Ventilation | 2 | 2014 | 33 | 0.200 |
Why?
|
| Hypertrophy | 2 | 2013 | 67 | 0.200 |
Why?
|
| Pulmonary Surgical Procedures | 1 | 2021 | 8 | 0.190 |
Why?
|
| United States | 6 | 2022 | 7108 | 0.190 |
Why?
|
| Exhalation | 2 | 2014 | 7 | 0.190 |
Why?
|
| Receptor, Endothelin A | 1 | 2021 | 21 | 0.190 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2015 | 1255 | 0.190 |
Why?
|
| Inpatients | 1 | 2024 | 312 | 0.180 |
Why?
|
| Precision Medicine | 2 | 2016 | 413 | 0.180 |
Why?
|
| Educational Measurement | 2 | 2014 | 231 | 0.180 |
Why?
|
| Follow-Up Studies | 4 | 2022 | 3680 | 0.180 |
Why?
|
| Delayed Emergence from Anesthesia | 1 | 2019 | 6 | 0.170 |
Why?
|
| Decision Making | 3 | 2021 | 670 | 0.170 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2019 | 7 | 0.170 |
Why?
|
| Biomarkers, Tumor | 3 | 2019 | 1545 | 0.170 |
Why?
|
| Feasibility Studies | 2 | 2023 | 785 | 0.170 |
Why?
|
| Clinical Protocols | 1 | 2020 | 158 | 0.170 |
Why?
|
| Contraindications | 1 | 2019 | 70 | 0.170 |
Why?
|
| Cryotherapy | 1 | 2019 | 30 | 0.170 |
Why?
|
| Steroids | 1 | 2020 | 173 | 0.170 |
Why?
|
| Postoperative Hemorrhage | 1 | 2019 | 46 | 0.170 |
Why?
|
| Hypotension | 1 | 2019 | 71 | 0.160 |
Why?
|
| Infection Control | 1 | 2020 | 124 | 0.160 |
Why?
|
| Adult | 9 | 2020 | 26822 | 0.160 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 270 | 0.160 |
Why?
|
| Hospitals | 1 | 2022 | 303 | 0.160 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 210 | 0.160 |
Why?
|
| Mortality | 1 | 2019 | 149 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2022 | 8273 | 0.150 |
Why?
|
| Intraoperative Complications | 1 | 2019 | 185 | 0.150 |
Why?
|
| Consensus | 1 | 2020 | 366 | 0.150 |
Why?
|
| Radiosurgery | 1 | 2021 | 287 | 0.150 |
Why?
|
| Needles | 1 | 2017 | 40 | 0.150 |
Why?
|
| Pilot Projects | 1 | 2020 | 872 | 0.150 |
Why?
|
| Computer-Assisted Instruction | 1 | 2017 | 44 | 0.140 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 6783 | 0.140 |
Why?
|
| Disease Progression | 3 | 2017 | 1469 | 0.140 |
Why?
|
| Respiratory Tract Fistula | 1 | 2017 | 9 | 0.140 |
Why?
|
| Pleural Diseases | 1 | 2017 | 14 | 0.140 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 983 | 0.140 |
Why?
|
| Muscle, Smooth | 2 | 2016 | 355 | 0.140 |
Why?
|
| Time | 1 | 2016 | 76 | 0.140 |
Why?
|
| Oscillometry | 2 | 2013 | 25 | 0.130 |
Why?
|
| Shock | 1 | 2016 | 44 | 0.130 |
Why?
|
| Electromagnetic Fields | 1 | 2016 | 26 | 0.130 |
Why?
|
| Spirometry | 3 | 2013 | 68 | 0.130 |
Why?
|
| Length of Stay | 1 | 2020 | 749 | 0.130 |
Why?
|
| Metals | 1 | 2016 | 93 | 0.130 |
Why?
|
| Logistic Models | 1 | 2019 | 1214 | 0.130 |
Why?
|
| Multicenter Studies as Topic | 1 | 2016 | 168 | 0.130 |
Why?
|
| Cryosurgery | 1 | 2016 | 55 | 0.130 |
Why?
|
| Electromagnetic Phenomena | 3 | 2021 | 18 | 0.130 |
Why?
|
| Fractals | 1 | 2015 | 42 | 0.130 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 1732 | 0.120 |
Why?
|
| Hot Temperature | 1 | 2016 | 207 | 0.120 |
Why?
|
| Prognosis | 4 | 2021 | 3798 | 0.120 |
Why?
|
| Curriculum | 2 | 2017 | 573 | 0.120 |
Why?
|
| Brachytherapy | 1 | 2016 | 120 | 0.120 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 1185 | 0.120 |
Why?
|
| Pulmonary Atelectasis | 2 | 2011 | 19 | 0.120 |
Why?
|
| Bronchoconstriction | 1 | 2014 | 56 | 0.120 |
Why?
|
| Hypoxia | 1 | 2019 | 657 | 0.120 |
Why?
|
| Biomechanical Phenomena | 1 | 2016 | 477 | 0.110 |
Why?
|
| Educational Status | 1 | 2014 | 195 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 1055 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 569 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 539 | 0.110 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 131 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2016 | 1862 | 0.100 |
Why?
|
| Secondary Prevention | 1 | 2013 | 159 | 0.100 |
Why?
|
| Airway Extubation | 1 | 2012 | 11 | 0.100 |
Why?
|
| Ventilator Weaning | 1 | 2012 | 24 | 0.100 |
Why?
|
| Risk Factors | 2 | 2020 | 5559 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2016 | 543 | 0.100 |
Why?
|
| Population Surveillance | 1 | 2013 | 216 | 0.100 |
Why?
|
| Photosensitizing Agents | 2 | 2023 | 51 | 0.100 |
Why?
|
| Nurse's Role | 1 | 2011 | 13 | 0.100 |
Why?
|
| Continuity of Patient Care | 1 | 2013 | 172 | 0.090 |
Why?
|
| Observer Variation | 1 | 2013 | 614 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 596 | 0.090 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2011 | 16 | 0.090 |
Why?
|
| Diagnostic Imaging | 2 | 2013 | 476 | 0.090 |
Why?
|
| Recurrence | 2 | 2010 | 1145 | 0.090 |
Why?
|
| Bronchomalacia | 1 | 2010 | 1 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2023 | 2887 | 0.090 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 402 | 0.090 |
Why?
|
| Terminology as Topic | 1 | 2011 | 222 | 0.080 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2009 | 37 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2014 | 1102 | 0.080 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2011 | 112 | 0.080 |
Why?
|
| Light Coagulation | 1 | 2009 | 6 | 0.080 |
Why?
|
| Bronchitis | 1 | 2009 | 7 | 0.080 |
Why?
|
| Tracheitis | 1 | 2009 | 3 | 0.080 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2009 | 8 | 0.080 |
Why?
|
| Equipment Design | 1 | 2010 | 422 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2009 | 144 | 0.080 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2009 | 58 | 0.080 |
Why?
|
| Prosthesis Design | 1 | 2009 | 299 | 0.080 |
Why?
|
| Polychondritis, Relapsing | 1 | 2008 | 5 | 0.080 |
Why?
|
| Tracheotomy | 1 | 2008 | 18 | 0.080 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2007 | 4 | 0.070 |
Why?
|
| Vital Capacity | 1 | 2007 | 69 | 0.070 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2007 | 15 | 0.070 |
Why?
|
| Hemoptysis | 1 | 2007 | 24 | 0.070 |
Why?
|
| Infant | 1 | 2014 | 3191 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 603 | 0.070 |
Why?
|
| Thoracic Vertebrae | 1 | 2007 | 51 | 0.070 |
Why?
|
| Spinal Neoplasms | 1 | 2007 | 49 | 0.070 |
Why?
|
| Algorithms | 1 | 2015 | 1913 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2767 | 0.070 |
Why?
|
| Respiratory Sounds | 1 | 2006 | 34 | 0.070 |
Why?
|
| Mediastinum | 2 | 2021 | 47 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 1607 | 0.060 |
Why?
|
| Syndrome | 1 | 2006 | 451 | 0.060 |
Why?
|
| Software | 1 | 2009 | 669 | 0.060 |
Why?
|
| Laryngoscopy | 1 | 2025 | 47 | 0.060 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2007 | 218 | 0.060 |
Why?
|
| Radiography | 1 | 2006 | 808 | 0.060 |
Why?
|
| Dihematoporphyrin Ether | 1 | 2023 | 4 | 0.050 |
Why?
|
| Granuloma | 1 | 2023 | 65 | 0.050 |
Why?
|
| Anesthesia, General | 1 | 2023 | 116 | 0.050 |
Why?
|
| Light | 1 | 2023 | 292 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2017 | 1498 | 0.050 |
Why?
|
| Ipilimumab | 1 | 2021 | 60 | 0.050 |
Why?
|
| Endoscopy | 1 | 2025 | 352 | 0.050 |
Why?
|
| SEER Program | 1 | 2022 | 205 | 0.050 |
Why?
|
| Calibration | 1 | 2021 | 103 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 1396 | 0.040 |
Why?
|
| Obesity | 1 | 2007 | 972 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2023 | 2655 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2019 | 50 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2007 | 2328 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2022 | 1704 | 0.040 |
Why?
|
| Medicare | 1 | 2022 | 427 | 0.040 |
Why?
|
| Air | 1 | 2017 | 62 | 0.030 |
Why?
|
| Time Factors | 1 | 2006 | 5359 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 2506 | 0.030 |
Why?
|
| Europe | 1 | 2017 | 324 | 0.030 |
Why?
|
| Biomarkers | 1 | 2022 | 1778 | 0.030 |
Why?
|
| Young Adult | 2 | 2018 | 6410 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 1075 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2017 | 958 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1801 | 0.030 |
Why?
|
| Vibration | 1 | 2011 | 50 | 0.020 |
Why?
|
| Knowledge | 1 | 2010 | 28 | 0.020 |
Why?
|
| Animals | 1 | 2010 | 27528 | 0.020 |
Why?
|
| Genomics | 1 | 2016 | 778 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 296 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 377 | 0.020 |
Why?
|
| Debridement | 1 | 2009 | 59 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1766 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2009 | 123 | 0.020 |
Why?
|
| Learning | 1 | 2010 | 286 | 0.020 |
Why?
|
| Bevacizumab | 1 | 2007 | 268 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 405 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2007 | 293 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 4168 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2007 | 952 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 3475 | 0.010 |
Why?
|